drugset / Trial / NCT05159830
Cannabidiol for Reducing Drinking in Alcohol Use Disorder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The non-psychotomimetic cannabis compound cannabidiol (CBD) has been found effective for reducing alcohol drinking in mice. Moreover, other experimental studies have found that CBD reduced alcohol-induced steatosis in the liver, and reduced alcohol-related injury in the brain. Despite these promising results from animal data, no human study has been conducted yet in alcohol use disorder (AUD).
Timeline
- Start
- 2024-10-25
- Primary completion
- 2026-02-26
- Completion
- 2026-02-26
Outcome
Outcome not reported
Stopped: “Péremption des unités de traitement prévue début juin 2026. Compte tenu des délais de traitement, aucune administration ne sera plus possible après le 1 février 2026. Ces facteurs ne permettent plus de garantir la poursuite des inclusions.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 600 mg | Oral |